Clinical Trial Update: To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males [Phase 2]

View source ↗

Summary

Phase 2 trial assessing GT20029 solution for androgenetic alopecia in Chinese adult males has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• GT20029

Snippet

Sponsor: Suzhou Kintor Pharmaceutical Inc, | Conditions: Alopecia, Male Pattern Hair Loss | Phase 2 | Status: COMPLETED